Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of… Grant US-11458119-B2 United States of America 04 Oct 2022
METHOD FOR DIAGNOSING CANCER, CANCER DIAGNOSIS COMPOSITION, CANCER DIAGNOSIS KIT, METHOD… Application WO-2021112225-A1 World Intellectual Property Organisation (WIPO) 10 Jun 2021
Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of… Grant US-10888547-B2 United States of America 12 Jan 2021
PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-10323011-B2 United States of America 18 Jun 2019
Method of treating polycystic kidney diseases with ceramide derivatives Grant US-10220039-B2 United States of America 05 Mar 2019
Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-i… Grant US-9974832-B2 United States of America 22 May 2018
Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's… Grant US-9797913-B2 United States of America 24 Oct 2017
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant US-9744153-B2 United States of America 29 Aug 2017
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant US-9745294-B2 United States of America 29 Aug 2017
Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitors Grant US-9546161-B2 United States of America 17 Jan 2017
Methods for Alzheimer's disease treatment and cognitive enhancement Grant US-9539235-B2 United States of America 10 Jan 2017
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and… Grant US-9481671-B2 United States of America 01 Nov 2016
Methods for Alzheimer'S disease treatment and cognitive enhancement Grant US-9446020-B2 United States of America 20 Sep 2016
Methods for Alzheimer's Disease treatment and cognitive enhancement Grant US-9345685-B2 United States of America 24 May 2016
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant US-9272996-B2 United States of America 01 Mar 2016
Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation Grant US-9188595-B2 United States of America 17 Nov 2015
Esters of DCPLA and methods of treatment using the same Grant US-9163032-B2 United States of America 20 Oct 2015
Methods for Alzheimer's disease treatment and cognitive enhancement Grant US-9066923-B2 United States of America 30 Jun 2015
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant US-8940776-B2 United States of America 27 Jan 2015
Method of treating polycystic kidney diseases with ceramide derivatives Grant US-8912177-B2 United States of America 16 Dec 2014
Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitors Grant US-8779163-B2 United States of America 15 Jul 2014
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and… Grant US-8729075-B2 United States of America 20 May 2014
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and… Grant US-8389517-B2 United States of America 05 Mar 2013
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant US-8309593-B2 United States of America 13 Nov 2012
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant US-8304447-B2 United States of America 06 Nov 2012
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors Grant US-8138353-B2 United States of America 20 Mar 2012
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors Grant US-7763738-B2 United States of America 27 Jul 2010
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors Grant US-7615573-B2 United States of America 10 Nov 2009
Amino ceramide-like compounds and therapeutic methods of use Grant US-7335681-B2 United States of America 26 Feb 2008
Amino ceramide-like compounds and therapeutic methods of use Grant US-7253185-B2 United States of America 07 Aug 2007
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors Grant US-7196205-B2 United States of America 27 Mar 2007
Amino ceramide-like compounds and therapeutic methods of use Grant US-6916802-B2 United States of America 12 Jul 2005
Amino ceramide-like compounds and therapeutic methods of use Grant US-6890949-B1 United States of America 10 May 2005
Amino ceramide-like compounds and therapeutic methods of use Grant US-6569889-B2 United States of America 27 May 2003
Amino ceramide-like compounds and therapeutic methods of use Grant US-6255336-B1 United States of America 03 Jul 2001
Amino ceramide-like compounds and therapeutic methods of use Grant US-6051598-A United States of America 18 Apr 2000
Amino ceramide-like compounds and therapeutic methods of use Grant US-6040332-A United States of America 21 Mar 2000
Amino ceramide-like compounds and therapeutic methods of use Grant US-5952370-A United States of America 14 Sep 1999
Amino ceramide-like compounds and therapeutic methods of use Grant US-5945442-A United States of America 31 Aug 1999
Amino ceramide--like compounds and therapeutic methods of use Grant US-5916911-A United States of America 29 Jun 1999